ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
4,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
5,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
5,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
7,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
8,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
9,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
10,1,Migraine,Migraine headaches,Headaches,Nerv,N
11,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
11,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
13,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
14,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
15,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
16,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
17,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
18,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
20,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
21,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
22,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
22,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
22,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
22,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
23,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
24,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
24,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
24,3,Headache,Headaches NEC,Headaches,Nerv,N
24,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
27,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
28,1,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
29,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
30,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
31,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
32,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
32,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
33,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
34,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
35,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
35,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
36,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
37,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
38,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
39,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
40,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
40,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
41,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
42,2,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
43,1,Acne,Acnes,Skin appendage conditions,Skin,N
43,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
44,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
45,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
46,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
47,1,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
48,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
49,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
50,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
50,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
51,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
51,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
52,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
53,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
54,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
55,1,Amblyopia,Amblyopic vision impairment,Vision disorders,Eye,N
56,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
56,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
56,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
57,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
57,3,Hepatitis chronic active,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
57,4,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
57,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
57,6,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
58,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
59,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
59,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
59,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
59,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
59,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
60,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
61,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
62,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
62,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Headache,Headaches NEC,Headaches,Nerv,N
63,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
63,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
64,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
64,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
66,1,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
67,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
68,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
69,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
70,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
71,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
72,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
73,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
73,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
73,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
74,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
75,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
76,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
77,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
79,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
80,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
81,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
82,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
83,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
84,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
85,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
86,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
87,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
88,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
89,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
90,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
91,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
92,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
92,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
93,2,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
94,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
95,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
95,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
96,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
96,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
96,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
96,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
98,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
98,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
99,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
100,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
101,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
102,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
103,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
103,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
104,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
105,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
107,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
107,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
108,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
109,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
109,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
110,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
111,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
112,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
113,1,Deafness,Hearing losses,Hearing disorders,Ear,N
114,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
115,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
116,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
117,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
117,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
117,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
117,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
117,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,1,Hypochromic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
119,1,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
119,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
119,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
120,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
121,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
122,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
123,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
124,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
125,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
126,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
126,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
127,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
128,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
129,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
130,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
131,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
131,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
131,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
131,5,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
133,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
135,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
135,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
135,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
136,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
138,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
139,1,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
140,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
141,1,Headache,Headaches NEC,Headaches,Nerv,N
142,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
144,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
145,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
146,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
147,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
147,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
148,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
149,1,Visual field defect,Visual field disorders,Vision disorders,Eye,N
149,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
150,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
151,1,Accommodation disorder,Refractive and accommodative disorders,Vision disorders,Eye,N
152,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
152,2,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
152,3,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
152,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
153,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
154,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
154,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
155,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
156,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
157,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
158,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
159,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
160,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
161,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
161,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
161,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
162,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
162,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
163,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
164,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
165,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
166,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
166,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
167,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
168,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
168,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
168,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
169,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
170,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
170,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
170,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
171,2,Retinal vascular disorder,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
171,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
172,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
172,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
172,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
173,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
173,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
174,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
175,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
176,1,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
176,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
177,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
178,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
178,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
178,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
179,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
180,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
181,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
182,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
183,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
183,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
183,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
184,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
184,2,Myopathy,Myopathies,Muscle disorders,Musc,N
184,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
185,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
186,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
186,2,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
186,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
186,4,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
187,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
187,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
187,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
188,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
188,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
190,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
190,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
191,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
192,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
193,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
194,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
195,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
196,1,Deafness,Hearing losses,Hearing disorders,Ear,N
196,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
196,3,Ear congestion,Ear disorders NEC,Aural disorders NEC,Ear,N
196,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
197,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
198,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
198,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
198,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
198,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
198,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
198,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
199,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
199,2,Headache,Headaches NEC,Headaches,Nerv,N
199,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
199,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
199,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
199,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
200,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
200,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
201,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
201,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
201,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
201,5,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
202,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
203,1,Crystal arthropathy,Crystal arthropathic disorders,Joint disorders,Musc,N
204,1,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
204,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
205,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
205,2,Optic nerve disorder,Visual pathway disorders,Vision disorders,Eye,N
206,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
206,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
208,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
208,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
208,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
209,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
209,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
209,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
209,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
210,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
211,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
211,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
212,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
213,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
214,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
214,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,4,Thrombosis in device,Device malfunction events NEC,Device issues,Prod,N
215,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
215,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
216,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
216,2,Bladder perforation,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
216,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
216,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
216,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
216,6,Disseminated Bacillus Calmette-Guerin infection,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
216,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
216,9,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
216,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
216,11,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
216,12,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
216,13,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
217,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
217,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
217,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
217,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
217,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
217,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
218,1,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
218,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
218,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
218,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
219,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
219,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
219,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
219,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
219,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
219,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
219,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
219,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
219,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
219,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
219,14,Headache,Headaches NEC,Headaches,Nerv,N
219,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
219,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,17,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
219,18,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
219,19,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
219,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,21,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
219,22,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
219,23,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
219,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,26,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
219,27,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
219,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
219,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,30,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
220,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
221,1,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
221,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
221,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
222,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
222,2,Headache,Headaches NEC,Headaches,Nerv,N
222,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
223,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
224,1,Toxic optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
225,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
226,1,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
226,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
226,3,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
226,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
226,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
227,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
228,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
229,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
229,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
229,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
229,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
230,1,Dyschromatopsia,Colour blindness (incl acquired),Vision disorders,Eye,N
230,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
230,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
230,4,Visual field defect,Visual field disorders,Vision disorders,Eye,N
231,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
231,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
231,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
234,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
234,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
235,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
236,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
237,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
238,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
238,2,Colour blindness,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
238,3,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
238,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
238,5,Visual pathway disorder,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
239,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
239,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
239,3,Repetitive speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
239,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
240,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
240,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
240,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
240,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
240,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
240,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
240,7,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
240,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,9,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
240,10,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
240,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
240,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
241,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
241,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
241,4,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
241,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
241,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
241,7,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
241,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
241,9,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
241,10,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
241,11,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
241,12,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
241,13,Intention tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
241,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
241,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
241,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,17,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
241,18,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
241,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
241,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
242,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
242,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
242,6,Headache,Headaches NEC,Headaches,Nerv,N
242,7,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
242,8,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
242,9,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
242,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
242,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
242,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
242,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
242,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
242,15,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
242,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
242,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
243,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
243,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
243,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
243,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
243,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
243,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
243,8,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
244,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
244,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
244,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
244,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
244,5,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
244,6,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
244,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
244,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
244,9,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
244,10,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
244,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
244,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
244,13,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
245,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
245,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
245,3,Headache,Headaches NEC,Headaches,Nerv,N
245,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
245,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
245,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
246,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
247,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
248,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
248,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
249,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
249,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
250,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
251,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
251,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
253,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
253,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
254,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
254,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
255,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
255,2,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
255,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
255,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
256,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
257,1,Meningitis tuberculous,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
257,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
258,1,Papillitis,Inflammations,General system disorders NEC,Genrl,N
259,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
259,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
259,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
260,1,Papillitis,Inflammations,General system disorders NEC,Genrl,N
260,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
261,1,Papillitis,Inflammations,General system disorders NEC,Genrl,N
261,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
262,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
262,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
263,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
263,2,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
264,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
264,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
264,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
265,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
265,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
266,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,3,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
266,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
266,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,6,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
266,7,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
266,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,9,Human herpesvirus 7 infection,Herpes viral infections,Viral infectious disorders,Infec,N
266,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
266,11,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
266,12,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
266,13,Monocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
266,14,Myalgia,Muscle pains,Muscle disorders,Musc,N
266,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
266,16,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
266,17,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
267,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
267,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
268,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
268,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
268,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
269,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
269,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
269,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
270,2,Mycobacterium avium complex infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
270,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
270,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
271,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
271,2,Myopathy,Myopathies,Muscle disorders,Musc,N
272,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
272,2,Myopathy,Myopathies,Muscle disorders,Musc,N
273,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
273,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,3,Myopathy,Myopathies,Muscle disorders,Musc,N
274,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
274,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
274,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
274,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
274,5,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
274,6,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
274,7,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
274,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
275,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
275,2,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
275,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
275,4,Septic rash,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
275,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
275,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
276,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
278,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
279,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
280,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
281,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
281,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
281,3,Subacute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
282,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
283,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
284,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
284,2,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
284,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,6,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
284,7,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
284,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,9,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
284,10,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
284,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
285,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
285,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
287,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
288,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
288,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
289,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
289,2,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
290,1,Joint lock,Joint related disorders NEC,Joint disorders,Musc,N
290,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
291,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
291,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
291,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
291,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
292,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
292,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
292,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
293,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
294,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
294,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
294,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
295,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
296,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
297,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
297,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
298,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
298,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
299,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
299,3,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
299,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,5,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
299,7,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,8,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,9,Bilirubin conjugated increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
299,11,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
299,13,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
299,14,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
299,15,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
299,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
299,17,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
299,18,Headache,Headaches NEC,Headaches,Nerv,N
299,19,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
299,20,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
299,21,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
299,22,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
299,23,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
299,24,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
299,25,Myalgia,Muscle pains,Muscle disorders,Musc,N
299,26,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
299,27,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
299,28,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
299,29,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
299,30,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
299,31,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
299,32,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
299,33,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
299,34,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
300,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
301,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
302,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
303,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
303,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
303,3,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
303,4,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
303,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
303,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
303,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
303,8,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
303,9,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
303,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
304,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
305,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
305,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
305,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
305,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
305,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
307,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
307,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
307,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
307,4,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
307,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
308,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
308,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
308,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
309,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
309,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
309,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
309,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
309,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
309,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
309,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
309,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
309,9,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
309,10,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
309,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
309,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
309,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
310,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
311,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
311,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
311,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
311,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
311,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
312,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
313,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
313,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
313,3,Vancomycin infusion reaction,Erythemas,Epidermal and dermal conditions,Skin,N
314,1,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
315,1,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
316,1,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
317,1,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
318,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
318,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
318,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
318,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
318,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
321,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
321,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
322,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
322,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
323,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
324,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
324,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
325,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
325,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
326,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
326,3,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
326,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
326,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
327,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
328,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
329,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
331,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
331,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
332,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
332,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
333,2,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
333,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
333,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
334,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
334,2,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
334,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
334,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
334,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
334,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
335,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
336,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
337,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
337,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
337,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
337,4,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
337,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
338,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
339,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
340,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
340,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
340,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
340,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
341,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
341,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
341,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
341,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
342,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
342,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
342,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
342,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
342,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
343,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
343,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
344,1,Headache,Headaches NEC,Headaches,Nerv,N
344,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
344,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
345,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
346,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
346,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
346,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
347,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
348,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
349,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
349,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
349,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
350,1,Ketonuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
350,2,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
350,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
350,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
350,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
350,6,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
350,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
351,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
351,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
352,2,Granulomatous liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
352,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
352,4,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
353,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
353,2,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
354,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
355,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
356,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
356,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
356,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
356,5,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
357,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
358,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
358,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
359,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
359,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
359,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
359,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
360,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
360,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
360,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
360,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
360,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,6,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,7,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
360,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
360,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
360,10,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
360,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
360,12,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
360,13,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
361,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
361,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
363,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
364,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
364,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
365,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
366,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
366,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
367,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
368,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
368,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
368,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
369,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
369,3,Subacute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
370,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
371,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
373,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
374,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
374,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
375,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
375,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
375,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
375,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
376,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
376,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
376,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
377,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
377,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
378,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
378,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
380,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
380,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
381,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
381,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
381,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
382,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
382,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
382,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
382,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
382,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
383,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
383,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
383,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
384,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
384,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
384,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
384,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
384,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
385,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
385,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
385,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
386,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
386,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
386,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
386,4,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
387,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
387,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
387,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
387,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
387,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
387,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
388,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
388,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
388,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
388,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
389,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
389,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
389,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
389,4,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
389,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
389,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
390,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
390,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
391,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
392,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
392,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
393,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
394,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
395,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
395,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
395,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
395,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
396,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
397,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
397,3,Migraine,Migraine headaches,Headaches,Nerv,N
397,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
398,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
399,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
400,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
401,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
402,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
403,1,Headache,Headaches NEC,Headaches,Nerv,N
404,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
404,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
404,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
404,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
405,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
407,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
